je.st
news
Home
› Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research
Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research
2015-11-25 01:19:03| drugdiscoveryonline Home Page
Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Infinity Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the discovery, development and delivery of medicines for difficult-totreat diseases, has expanded its use of the Medidata Clinical Cloud.
Tags: research
selected
solution
advance
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||